Actinium Pharmaceuticals
ATNM
$9.69
Share price
0.00%
Change (1 day)
8.27%
Change (1 year)
Categories
EPS for Actinium Pharmaceuticals (ATNM)
EPS in 2023 (TTM): -$1.82
According to Actinium Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.82. In 2022 the company made an earnings per share (EPS) of -$1.37 a decrease over its 2021 EPS that were of -$1.20.
EPS history for Actinium Pharmaceuticals from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.82 | 32.85% |
| 2022 | -$1.37 | 14.17% |
| 2021 | -$1.20 | -43.4% |
| 2020 | -$2.12 | -52.98% |
| 2019 | -$4.51 | -31.68% |
| 2018 | -$6.60 | -46.34% |
| 2017 | -$12.30 | -18% |
| 2016 | -$15.00 | -9.09% |
| 2015 | -$16.50 | -38.89% |
| 2014 | -$27.00 | 91.49% |
| 2013 | -$14.10 | -88.41% |
| 2012 | -$121.64 | 1251.63% |
| 2011 | -$9.00 | 3.2423204348652E+19% |
| 2010 | -$0.0000000000 | |
| 2009 | N/A | -100% |
| 2008 | -$0.30 | -39.06% |
| 2007 | -$0.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | -$0.52 | -71.43% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.64 | -64.84% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -142.78% | 🇺🇸 USA |